Endpoint Health
Palo Alto
About Endpoint Health
Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-powered patient discovery platform, to identify and match high-potential therapies to the patients most likely to respond.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $64.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: endpointhealth.com
Industries & Categories
Health Care
Social Profiles
Canonical: https://fsome.com/organization/endpoint-health-125369 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.